Premium
Can serological methods help distinguish between prophylactic and alloimmune anti‐D?
Author(s) -
Irving C.,
Crennan M.,
Vanniasinkam T.
Publication year - 2017
Publication title -
transfusion medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.471
H-Index - 59
eISSN - 1365-3148
pISSN - 0958-7578
DOI - 10.1111/tme.12420
Subject(s) - serology , medicine , agglutination (biology) , antibody , immunology , direct agglutination test , obstetrics
SUMMARY Objectives Enzyme indirect antiglobulin test ( EIAT ) and polyethylene glycol IAT ( PIAT ) were evaluated for their potential use as tests to distinguish between prophylactic and alloimmune anti‐D in plasma by comparing with a tube variation of the standard low ionic strength solution‐ IAT ( LISS‐IAT ). Background Laboratories performing the screening of RhD ‐negative pregnant women are required to provide clinicians with guidance as to the source of detected RhD antibodies. Currently, this is derived from RhIg immunoprophylaxis history, agglutination scores and titration results, where performed. A serological test that can differentiate between prophylactic and alloimmune anti‐D would be useful in the diagnosis of RhD alloimmunisation in pregnant women. Materials and Methods Plasma samples ( n = 273) [fresh (collected from April 2014 to February 2015) and frozen (up to 2 years)] from antenatal females, preoperative males and females over child‐bearing age were used in this study. Samples were identified as containing anti‐D by routine column agglutination ( CAT ) and were tested by tube LISS‐IAT , EIAT and PIAT , and a score difference was calculated. Results A total of 32% of alloimmune anti‐D samples demonstrated an increase in agglutination score (+2 or +3) when tested by EIAT . A significant increase in agglutination score for alloimmune samples using EIAT compared with LISS‐IAT was observed. EIAT had a sensitivity (Sn) of 59%, positive predictive value ( PPV ) of 100% and specificity (Sp) of 100% for alloimmune anti‐D. Conclusion EIAT is capable of confirming but not excluding the presence of alloimmune anti‐D in samples where anti‐D is detected in routine antibody screening.